Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement

Nature Reviews Endocrinology, Journal Year: 2023, Volume and Issue: 19(12), P. 722 - 740

Published: Sept. 5, 2023

Language: Английский

---

Consensus on criteria for acromegaly diagnosis and remission

Pituitary, Journal Year: 2023, Volume and Issue: unknown

Published: Nov. 3, 2023

Abstract Purpose The 14th Acromegaly Consensus Conference was convened to consider biochemical criteria for acromegaly diagnosis and evaluation of therapeutic efficacy. Methods Fifty-six experts from 16 countries reviewed discussed current evidence focused on assays; the role imaging, pathology, clinical assessments; consequences diagnostic delay; remission recommendations follow up; value assessment monitoring in defining disease progression, selecting appropriate treatments, maximizing patient outcomes. Results In a with typical features, insulin-like growth factor (IGF)-I > 1.3 times upper limit normal age confirms diagnosis. Random hormone (GH) measured after overnight fasting may be useful informing prognosis, but is not required For patients equivocal results, IGF-I measurements using same validated assay can repeated, oral glucose tolerance testing might also useful. Although primary treatment outcome, findings should interpreted within context acromegaly. Follow up assessments effectiveness, imaging studies evaluating residual/recurrent adenoma mass, signs symptoms acromegaly, its complications, comorbidities. Referral multidisciplinary pituitary center considered biochemical, or at diagnosis, insufficiently responsive standard approaches. Conclusion highlight new understandings disordered GH importance expert management this rare disease.

Language: Английский

---

A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis

The Lancet Diabetes & Endocrinology, Journal Year: 2024, Volume and Issue: 12(3), P. 209 - 214

Published: Jan. 29, 2024

Language: Английский

---

Splicing diversity enhances the molecular classification of pituitary neuroendocrine tumors

Nature Communications, Journal Year: 2025, Volume and Issue: 16(1)

Published: Feb. 11, 2025

Pituitary neuroendocrine tumors (PitNETs) are one of the most common intracranial with diverse clinical manifestations. Current pathological classification systems rely primarily on histological hormone staining and transcription factors (TFs) expression. While effective in identifying three major lineages, molecular characteristics based hormones TFs lack sufficient resolution to fully capture complex tumor heterogeneity. Transcriptional diversity by alternative splicing (AS) offered additional insight address this challenge. Here, we perform bulk full-length single-cell RNA sequencing comprehensively investigate AS dysregulation across all PitNET lineages. We reveal pervasive dysregulations that better depict Additionally, delineate fundamental heterogeneity at resolution, confirming findings refining varying among cell types. Notably, effectively distinguish silent corticotroph subtype define a distinct TPIT lineage subtype, which is associated worse outcomes increased abnormalities driven altered ESRP1 In conclusion, our results characterize specific landscape PitNETs, enhancing understanding PitNETs subtyping. pituitary factors. authors analyze revealing subtypes abnormalities.

Language: Английский

---

Clinical and prognostic implications of pituitary macroadenomas (PitNets) grading: a monocentric experience

Pituitary, Journal Year: 2025, Volume and Issue: 28(2)

Published: March 13, 2025

Language: Английский

---

Radiological and Immunohistochemical Characteristics of PitNETs in 79 Patients Undergoing Neurosurgery

Cancers, Journal Year: 2025, Volume and Issue: 17(4), P. 666 - 666

Published: Feb. 16, 2025

The human pituitary is a gland located within small bony box, the sella turcica, under base of brain [...]

Language: Английский

---

Predictors of testosterone recovery in male patients with nonfunctioning pituitary adenoma treated with transnasal transsphenoidal extrapseudocapsular microsurgery

Metabolism and Target Organ Damage, Journal Year: 2025, Volume and Issue: 5(1)

Published: Feb. 17, 2025

Aim: To investigate the predictor of hypothalamic-pituitary-gonadal (HPG) axis recovery in male pituitary adenoma patients with trans-sphenoid extrapseudocapsular microsurgery. Methods: From June 2019 to December 2021, we retrospectively analyzed clinical data gonadal hormone changes and resection degree before after surgery nonfunctioning (NFPA) who underwent microsurgical by pseudocapsule technique same treatment group at Department Neurosurgery, Tongji Hospital. We explored predictors affecting postoperative testosterone using logistics regression analysis. Results: Among 291 adenomas, mean age was 50 years. Preoperative lower than normal 127 (43.6%); total subtotal were performed 279 (95.9%) 12 (4.1%), respectively. Postoperative follicle-stimulating (FSH) elevated 224 (77.0%) patients, luteinizing (LH) 230 (79.0%) prolactin significantly decreased 259 (89.0%) patients. Seventy-one low preoperative levels recovered levels. Univariate multivariate analysis suggested that tumor size, coagulative necrotic apoplexy (CNPA), invasiveness (P < 0.05). Conclusion: For NFPA, transsphenoidal extra-pseudocapsule microsurgery can effectively restore function anterior gland promote testosterone. Tumor CNPA

Language: Английский

---

Does a Transcriptionally Active HPV Infection Affect the Invasiveness of Pituitary Neuroendocrine Tumors? A Case Series Study of 60 Patients in Krakow, Poland

Cancers, Journal Year: 2025, Volume and Issue: 17(4), P. 684 - 684

Published: Feb. 18, 2025

Pituitary neuroendocrine tumors (PITNETs) often show a tendency towards invasive behavior, i.e., an invasion the cavernous sinuses or destruction of sella turcica. In present study, we analyzed whether transcriptionally active HPV infection affects invasiveness pituitary tumors. Sixty patients with different phenotypes PITNETs who underwent neurosurgery were studied. The obtained postoperative material was histopathologically. For each patient, formalin-fixed paraffin-embedded blocks cut into ultra-thin slices and two to three them designated for DNA extraction, while one used histological slides. Based on isolated DNA, presence from individual types determined by real-time detection polymerase chain reaction using REALQUALITY RQ-Multi Detection reagent kit (AB ANALITICA, Italy). P16 protein expression assessed immunohistochemical staining A distinguished when overexpression detected simultaneously given tumor. group 60 PITNETs, high-risk in subset 11 (18.3%). This associated significantly lower probability tumor invasiveness, measured both Knosp (OR = 0.11, 95% CI: 0.02-0.58) Hardy scales 0.12 0.024-0.56). Further studies are needed confirm prevalence infections adenomas role these

Language: Английский

---

Clinical, surgical, and endocrine outcome following treatment of posterior pituitary tumors: a retrospective cohort study

Pituitary, Journal Year: 2025, Volume and Issue: 28(2)

Published: April 1, 2025

Abstract Purpose This study evaluates the clinical presentation, endocrine dysfunction, surgical outcome, and long-term prognosis in patients with histologically confirmed posterior pituitary tumors (PPTs). Methods A retrospective cohort was conducted on 19 treated for PPTs at a single center between 2000 2023. Data clinical, endocrine, outcomes were collected analyzed. Results The included 3 pituicytomas (PCs), 8 granular cell (GCTs), spindle oncocytomas (SCOs) patients, female predominance (58%) mean age of 57.2 ± 13.2 years. Symptoms leading to diagnosis headache (31.6%), visual impairment (21%), sexual dysfunction (10.5%). GCT had higher preoperative BMI (34.49 5.72) compared PC (22.12 2.40) SCO (24.74 4.24) ( p < 0.01). Postoperative increased across all groups, GCTs showing steepest rise Endocrine largely persisted or worsened after surgery, limited recovery follow-up. Surgical approaches transsphenoidal (48%) transcranial (52%), achieving gross total resection 58% cases. Tumor recurrence occurred 16% requiring adjuvant radiation therapy. Tumor-specific survival 5 years 100% an overall rate 80% where non-tumor-related comorbidities accounted observed mortality. Conclusion are rare significant metabolic consequences. While management is associated favorable tumor-specific survival, persistent postoperative progressive underscore need follow-up targeted interventions. These findings contribute understanding PPT biology support development optimized strategies.

Language: Английский

---

Does New WHO 2022 Nomenclature of Pituitary Neuroendocrine Tumors Offer an Extra Edge to the Neurosurgeons for Its Management? A Narrative Review

Asian Journal of Neurosurgery, Journal Year: 2024, Volume and Issue: 19(02), P. 107 - 111

Published: June 1, 2024

The new World Health Organization nomenclature of pituitary tumors was introduced in the year 2022 after much deliberation. This clearly demarcates anterior lobe (adenohypophyseal), posterior (neurohypophyseal), and hypothalamic tumors. There is also focus on other arising sellar region. has advocated routine use immunohistochemistry describing transcription factors that plays a fundamental role distinguishing cell lineage these However, complex understanding due to inclusion pathological correlates like factors, hormones, biomarkers, various controversies have emerged regarding renaming adenomas (PA) as PiTNETs ("Pituitary Neuroendocrine tumors") because majority are benign rare metastatic behavior while classifying them will create unnecessary misinterpretation aggressive lead apprehension among patients. classification gives deeper insight into histological picture but than contributing follow-up strategy postsurgery management, this does not add anything could be advantageous for neurosurgeons clinical practice decision making, especially deciding plan action surgery. Hence, there need more comprehensive, integrated, neuroradiological-based with emphasis invasiveness would assist planning treatment managing patients

Language: Английский

---